Status:
TERMINATED
Kinetics of Microparticles Under Chemotherapy in Patients With Gastric or Pancreatic Cancer
Lead Sponsor:
Poitiers University Hospital
Conditions:
Pancreatic Cancer
Gastric Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Microparticles have recently emerged as a thrombotic risk marker with a potential role in determining which patients are at greatest risk for developing thrombosis. Available data show an increase in ...
Eligibility Criteria
Inclusion
- First-line chemotherapy indicated and accepted by the patient for pancreatic cancer or gastric cancer
- Confirmed diagnosis of pancreatic cancer or gastric cancer
- Free subject, without guardianship or trusteeship or subordination
- Patient benefiting from a social security scheme or benefiting through a third party
- Consent given by the patient after clear and fair information about the study
Exclusion
- Age \< 18yo
- Life expectancy ≤10days
- Deep vein thrombosis ou pulmonary embolism ≤3months
- Patient unable to receive chemotherapy (sepsis, acute coronary syndrome, recent stroke, heparin-induced thrombocytopenia, disseminated intravascular coagulation)
- Person enjoying enhanced protection, namely minors, persons deprived of their liberty by a judicial or administrative decision, persons staying in a health or social institution, adults under legal protection, and finally patients in emergency situations
- Pregnant or lactating woman and woman of childbearing age lacking effective contraception
Key Trial Info
Start Date :
July 23 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 2 2020
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT03471468
Start Date
July 23 2018
End Date
January 2 2020
Last Update
February 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU of Poitiers
Poitiers, France, 86000